NSU Newsroom

SharkBytes

Horizons

This version of NSU News has been archived as of February 28, 2019. To search through archived articles, visit nova.edu/search. To access the new version of NSU News, visit news.nova.edu.

This version of SharkBytes has been archived as of February 28, 2019. To search through archived articles, visit nova.edu/search. To access the new version of SharkBytes, visit sharkbytes.nova.edu.

News Releases Archive

Contact

Division of Public Relations and Marketing Communications
Nova Southeastern University
3301 College Avenue
Fort Lauderdale, Florida 33314-7796

nova.edu/prmc

SharkBytes Archives

Contact

Division of Public Relations and Marketing Communications
Nova Southeastern University
3301 College Avenue
Fort Lauderdale, Florida 33314-7796

(954) 262-5353
(800) 541-6682 x25353
Fax: (954) 262-3954
communications@nova.edu

NSU Professor Speaks with WLRN About Vivitrol

According to the National Institute on Drug Abuse, more than 115 people in the U.S. die every day after overdosing on opioids. For people who try to seek help with addiction, many turn to treatment to reduce cravings.

Vivitrol is a medication that is approved by the FDA to treat opioid addiction. Broward County recently approved to include it to its tools in order to help addicts receive the treatment they need to quit.

Scott Kjelson, Pharm.D., CPh., assistant professor at NSU’s College of Pharmacy, spoke with WLRN about the price of the medication and how political money shouldn’t stop what the drug can do for people.

Scott Kjelson, Pharm.D., CPh.

Scott Kjelson, Pharm.D., CPh.

To listen to the interview, click the link below: